Third-Generation Cephalosporins
The third-generation cephalosporins include cefotaxime, ceftriaxone, ceftazidime, ceftizoxime, cefoperazone, cefpodoxime, ceftibuten, cefixime, cefdinir, and cefmenoxime. 1, 2, 3, 4, 5, 6
Parenteral (IV/IM) Third-Generation Cephalosporins
The injectable third-generation agents include:
- Ceftriaxone - Distinguished by its long half-life (~8 hours) allowing once-daily dosing 4, 6
- Cefotaxime - Excellent gram-positive coverage among third-generation agents 6
- Ceftazidime - One of only two third-generation drugs providing antipseudomonal coverage 6, 7
- Cefoperazone - The other agent with antipseudomonal activity; primarily eliminated in bile 4, 6
- Ceftizoxime - Considered the "workhorse" third-generation cephalosporin 7
- Cefotetan - Eliminated primarily via kidneys with half-life of 1.5-2.5 hours 4
These parenteral agents are not suitable for oral administration 4. Most have elimination half-lives ranging between 1.5-2.5 hours, except ceftriaxone 4. The major route of elimination is renal for most agents, while cefoperazone is mainly eliminated in bile, and cefotaxime and ceftriaxone depend on both liver and kidneys 4.
Oral Third-Generation Cephalosporins
The oral third-generation cephalosporins include:
- Cefpodoxime - Suitable agent for sinusitis 1
- Cefdinir - Appropriate for sinusitis but has poor activity against penicillin-resistant S. pneumoniae; has low urinary excretion (13-23%) and low oral absorption (25%) 1, 2
- Ceftibuten - Has poor activity against S. pneumoniae and is especially ineffective against penicillin-resistant strains; should not be used for acute bacterial sinusitis 1
- Cefixime - Has poor activity against S. pneumoniae and is especially ineffective against penicillin-resistant strains; should not be used for acute bacterial sinusitis 1
Important Clinical Considerations
When choosing an oral cephalosporin for complicated urinary tract infections, both oral absorption and urinary excretion are relevant parameters for consideration. 8, 2 Observational studies suggest that third-generation oral cephalosporins may be comparable to oral fluoroquinolones or trimethoprim-sulfamethoxazole as step-down therapy in patients with complicated UTI and gram-negative bacteremia 8, 2.
However, cephalosporins with low bioavailability (such as cefdinir) should be used cautiously and with optimized dosing 8, 2. Studies have shown that readmissions for UTI were higher in patients who received cefdinir compared to those who received fluoroquinolones or trimethoprim-sulfamethoxazole 8, 2.
Third-generation cephalosporins penetrate adequately into cerebrospinal fluid (except cefoperazone) and are indicated for treatment of bacterial meningitis. 6, 9 Their proven clinical efficacy, favorable pharmacokinetics, and low frequency of adverse effects make them preferred antibiotics in many clinical situations 6.